AML digital therapeutic lands Breakthrough Device Designation
Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.
United States Michelle Rubin Onur Mro Michelle Rubin Onur Areej El Jawahri Drug Administration Breakthrough Device Designation
Source: outsourcing-pharma.com